INTERGARD SYNERGY UltraThin Grafts
The next generation antimicrobial vascular graft.
Maquet: committed to innovation
INTERGARD SYNERGY is the first vascular prosthesis combining two well-known antimicrobial agents: silver acetate and triclosan. While silver acetate and triclosan are effective antimicrobial agents alone, their power to prevent development of infection is intensified when combined and offers increased antimicrobial properties. In vitro testing of the INTERGARD SYNERGY vascular graft demonstrates antimicrobial efficacy against a broad spectrum of micro-organisms including MRSA (Methicillin Resistant Staphylococcus Aureus) and is substantially more effective than the first generation INTERGARD SILVER graft. 1,2
The majority of vascular graft infections occur at the time of implant, or in the immediate postoperative period.2 The release profile of the combined silver acetate and triclosan is designed to be most active during the initial 24 hours post implant, with continuous and substantial release for a 6 days period.3 In vitro and in vivo testing have proven the effectiveness of INTERGARD SYNERGY against a broad spectrum of microorganisms including MRSA and Staph Epi, with sustained effectiveness beyond 7 days. 4
INTERGARD SYNERGY UltraThin is specifically designed for peripheral procedures where the incidence of graft infection is highest. One of the thinnest peripheral grafts on the market, INTERGARD SYNERGY UltraThin is a small diameter graft with exceptional handling and suturing characteristics.
 Data on file
 In vitro evaluation of the antimicrobial efficacy of a new silver-triclosan vs a silver collagen-coated polyester vascular graft against methicillin-resistant Staphylococcus aureus. Ricco JB, Assadian A, Schneider F, Assadian O., J Vasc Surg. 2012 Mar;55(3):823-9. Epub 2011 Nov 10.
 Data on file
 Bandyk DF, Bergamini TM, Common complications of vascular surgery: preventation and management. Infection in prosthetic vascular grafts (36); 588-604.
The proprietary ultra thin wall construction of INTERGARD SYNERGY UltraThin produces a small diameter graft with exceptional handling and suturing characteristics. With awall thickness of just 0.35 mm, INTERGARD SYNERGY UltraThin is one of the thinnest antimicrobial peripheral graft on the market. The unique polyester matrix creates a compliant vessel due to its pulsatility.
INTERGARD SYNERGY UltraThin is available in configurations specially designed for peripheral procedures where the incidence of graft infection is highest.
- Radial and longitudinal pulsatility
- No suture hole bleeding
- Excellent host vessel conformability
- Available with optional radial support